A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
Clinical trial NCT00289627 · COMPLETED
Trial details
- NCT number
- NCT00289627
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2007-07-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.